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ABSTRACT  
Vijayasar (Pterocarpus marsupium) has been mentioned in Charak Samhita, as a 
remedy for Madhumeha (Diabetes Mellitus). A study conducted by ICMR (Indian 
Council of Medical Research) revealed that the hypoglycemic effects of Vijayasar 
are comparable to that of tolbutamide. Karela (Mormordica charantia) is another 
herb used in Madhumeha and it is a routinely used vegetable in Nepal. In this 
study we measured the effectiveness of Karela in patients of Madhumeha and 
compared with that of Vijayasar. A total of sixty four patients diagnosed with 
Madhumeha (Fasting Blood Glucose ≥126mg/dl or Post Prandial Blood 
Glucose≥200mg/dl) were given either Karela or Vijayasar powder two times a 
day for one month, along with dietary and lifestyle advices and their blood 
glucose levels were measured before initiating treatment and after one month of 
treatment. Changes in the subjective complaints of Madhumeha like 
Prabhutamutrata, Avilmutrata, etc. and appearance of adverse events were also 
evaluated. Randomization of treatment was done and dosage was titrated on the 
basis of glycemic control and duration of Madhumeha. The mean reductions in 
fasting blood glucose and post prandial blood glucose in Karela treated group 
are 60.83 mg/dl and 79.74 mg/dl respectively and that in Vijayasar treated. 
Karela is a safe and effective medicine in the management of Madhumeha and it 
is as effective as Vijayasar. 
INTRODUCTION
 Ayurveda is the science of life which addresses 
the physical, mental as well as the spiritual aspects of 
health. Ayurveda is the first medical science in which 
there are vivid descriptions of the diagnosis and 
management of Madhumeha. Madhumeha has been 
described by Vagbhatta as one of the Maharogas 
(difficult to treat diseases.[1] and it is also one of the 
twenty types of Prameha mentioned in Ayurveda. Charak 
has mentioned that due to excessive intake of Nidana 
(etiological factors) like Guru (heavy), Snigdha (oily), 
Amla (sour), Lavana (salty) food items; newly harvested 
food and fresh drinks; excessive sleep, physical inactivity, 
etc., there is increase in Kapha, Pitta dosha and Meda 
(fatty tissue) Mamsa (muscle) Dhatus. This increased 
Kapha, Pitta, Meda and Mamsa obstructs the path of vata 
and causes its abnormality. This disturbed Vata carries 
Oja (essence of body) into the Mutrasaya (Mutravaha-
srotas) and results the disease Madhumeha[2]. The clinical 
features of Prameha are “Prabhutmutrata” and 
“Avilmutrata” meaning voluminous and frequent 
excretion of turbid urine. Madhumeha is a subtype of 
Prameha so these criteria will also apply to Madhumeha. 
Charak has mentioned the specific clinical features of 
Madhumeha as “passage of Kasaya (astringent), Madhura 
(sweet), Pandu (pale) and Rukshya (unoily) urine”[3]. 
Sushruta has described two types of Prameha – Sahaj 
(genetic) and Apathyanimittaja (improper diet/lifestyle 
induced) and mentioned their clinical features as 
follows:[4] 
1. Sahajprameha: Krisha (thin), Rukshya (Dry), Alpasi 
(Eats less), Pipasubhrisham (Polydipsia) and 
Parisharansheel (Active habits).  
2. Apathyanimittaja: Sthula (Obese), Bahawasi 
(Polyphagia), Snigdha (oily skin) and Saiyaswopna-
sheela (Sits idle, lies down and sleeps). 
 Vagbhata in Astanga Hridaya has described the 
clinical features of Madhumeha as “madhusamam” 
(passage of honey like urine) and “madhuryachhatano-
rata” (sweetness in the body).[5] 
 Madhumeha or diabetes mellitus is one of the 
oldest ailments afflicting human beings. With changing 
demographics and lifestyle, the prevalence of diabetes is 
rising exponentially all over the world especially in the 
developing countries like Nepal. A study conducted in the 
7 urban cities of Nepal revealed that the prevalence of 
diabetes, IGT (impaired glucose tolerance) and IFG 
(Impaired fasting glucose) was 19.0%, 10.6%, and 9.9 % 
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respectively in the population aged ≥40 years[6]. The 
prestigious Journal ‘The Lancet’ once wrote in its 
editorial “medicine might be winning the battle of 
glucose control but it is losing the war against 
diabetes”.[7] This quote largely represents the current 
scenario, where on one hand there is ever increasing 
investment in newer interventions for diabetes mellitus 
and on the other hand its prevalence and subsequent 
complications are increasing anyway. Diabetes is a 
metabolic disorder affecting multiple organ systems at 
the same time. It brings with itself the various metabolic 
complications of hyperglycemia both acute and chronic 
affecting almost every organ in our body. It has 
significant impact on the quality of life of an individual 
and it adds the burden to the national healthcare as more 
cases are being added for long term management. As 
diabetes is often associated with obesity, dyslipidemia, 
hypertension, insulin resistance, known as metabolic 
syndrome, an intervention capable of handling all these 
associated conditions is necessary. Diabetes should 
never be viewed merely as increased level of blood 
glucose. Trying to cure lifestyle related chronic diseases 
(diabetes mellitus) with pharmaceutical medicine is like 
“trying to dry out a flooded room without turning off the 
tap”. Ayurveda promises a perfect solution to this 
problem as it offers effective modalities of lifestyle 
management via Sadvrit, Yoga, Dincharya and 
Ritucharya; and drugs with the potential to act on 
associated conditions in diabetes like dyslipidemia, 
hypertension, and obesity besides hyperglycemia. 
 There are basically two modalities of blood 
glucose control currently available in the conventional 
Western Medicine i.e. oral hypoglycemic agents and 
insulin. Both these agents have numerous side effects 
which add risks to the health of the patient. The 
biguanides group of oral hypoglycemic agents 
(Metformin) commonly causes gastrointestinal 
disturbances like nausea, diarrhea, abdominal 
discomfort; and sometimes severe life threatening events 
like lactic acidosis. The sufonylurea group or the insulin 
secretagogues cause hypoglycemia as their commonest 
side effect and other infrequent ones are nausea, skin 
reactions and abnormal liver function tests. The use of 
sulfonylurea group of oral hypoglycemic agents has also 
been associated with adverse coronary artery disease 
outcome. It has been hypothesized that sulfonylurea 
prevent vasodilation at the time of myocardial infarction. 
These insulin secretagogue agents are also supposed to 
cause beta cell exhaustion and ultimately beta cell failure 
requiring insulin for blood glucose control. 
Hypoglycemia is the commonest side effect of insulin 
therapy besides the hypokalemia which usually occurs in 
intravenous use. In type two diabetes, there is also 
possibility of insulin resistance and the dose of insulin 
keeps on increasing. Being an anabolic hormone, insulin 
also promotes weight gain and atherosclerosis. Ayurveda 
promises solution to this problem as it offers effective 
modalities of lifestyle management via Sadvrit, Yoga, 
Dincharya and Ritucharya; and drugs with the potential 
to act on associated conditions in diabetes like 
dyslipidemia, hypertension, and obesity besides 
hyperglycemia with fewer side effects if any.The need of 
a novel drug with equal potency for blood glucose 
control but without the adverse effects was felt and thus 
this research was conducted. There are a number of 
plants described in Ayurveda for the management of 
Madhumeha that are both safe and effective. These plants 
have an advantage of being used in the community for 
centuries. So, preliminary trials like toxicity studies in 
animals may not be necessary for them. Clinical trials are 
necessary to provide evidence base to support or refute 
their efficacy. Clinical trials to make comparison with 
conventional medicine as well as to compare two or 
more Ayurvedic medicines need to be carried out. Karela 
and Vijayasar have been used for the management of 
Madhumeha for many centuries. Several studies have 
been conducted around the world on these herbs 
assessing their effectiveness. Most of these studies 
showed that these two are effective in controlling blood 
glucose.[8-12] Large scale randomized controlled trials 
comparing Ayurvedic medicine with conventional 
medicines can be done to provide evidence of their 
efficacy. Studies comparing two or more of Ayurvedic 
medicines used for same disease also need to be 
conducted, so that the choice of drug for a specific 
condition could be determined.  
 Vijayasar was not found to have any effect on the 
lipid profile of the participants[11] while Karela showed 
its effect on lipid profile, serum sialic acid, besides blood 
sugar[12]. It was found that fruit extract of MC 
(Mormordica charantia), exhibited hypolidemic effect in 
streptozotocin induced diabetic rats. Though, statistically 
not significant, there was reduction in body weight and 
blood pressure in those experimental mice treated with 
Karela [12]. To test the hypothesis that Karela induces the 
same effects on blood glucose of Nepalese population, 
this study was conducted. The reduction in blood 
pressure and body weight was also expected in those 
treated with Karela. Some research work has been done 
regarding the effectiveness of Vijayasar in Madhumeha in 
India including some RCTs (Randomized controlled 
trails)[11], so it has been taken as the reference or 
standard treatment and Karela was taken as 
experimental treatment.  
Objectives 
The objectives of this study were to 
 To determine the effectiveness of Karela (Mormordica 
charantia Linn.) on blood glucose of patients with 
Madhumeha (Diabetes mellitus type II). 
 To determine the effectiveness of Vijayasar 
(Pterocarpus marsupium Roxb.) on the blood glucose of 
patients with Madhumeha (Diabetes mellitus type II).  
 To compare the effectiveness of Karela and Vijayasar 
on the blood glucose of patients with Madhumeha. 
MATERIALS AND METHODS 
Study Subjects 
 Patients diagnosed with Madhumeha (type two 
diabetes mellitus) were taken in and those fulfilling the 
inclusion criteria were given either Karela or Vijayasar 
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for one month. Patients were collected from the OPD 
(Outpatient Department) and IPD (In Patient 
Department) of TUATH (Tribhuvan University Ayurveda 
Teaching Hospital), Kirtipur and from various health 
clinics in Kathmandu at Boudha, Moolpani, Maharajgunj 
and New road. Ethical approval for this study was 
obtained from the IRB (Institutional Review Board), IOM, 
TU. Informed consent was obtained before initiating 
treatment.  
Inclusion Criteria 
 Patients with Madhumeha (Type II diabetes mellitus) 
based on ADA Clinical Practice Recommendations 
2011 i.e. fasting blood glucose of ≥126mg/dl or post-
prandial blood glucose of ≥200mg/dl. 
 Patients of age 16-70 years. 
Exclusion Criteria 
 Fasting blood glucose ≥250. 
 BMI≤19 kg/m2. 
 Type 1 diabetes mellitus 
 Acute complications of hyperglycaemia like DKA 
(Diabetic Ketoacidosis), HHS (Hyperglycemic 
Hyperosmolar State). 
 Serum Creatinine ≥2.5 mg/dl. 
 Cardiac conditions like Myocardial Infarction, 
Ischemic Heart Disease.  
 Blood Pressure ≥ 180/110mm of Hg. 
 Pregnancy or lactation. 
 Patients unwilling to give informed consent. 
 A total sample size of 56 was determined 
initially for this study but later on considering the 
randomization sequence to be complete, amendment in 
the protocol was made 64 subjects were taken.  
Interventions 
 The powder preparation and packaging of 
Karela and Vijayasar was done according to the WHO 
GMP guidelines for herbal medicines at Shivadarshan 
Herbal Udyog, Dhapasi, Kathmandu Nepal. The dosage of 
Karela powder was 3-6 grams and that of Vijayasar was 
2-4 grams. Participants were advised to take the 
medicine half an hour before lunch and dinner with 
water as Anupana (adjunct). Advice regarding 
Pathyapathya (dietary schedule) was also given after 
inquiring about their dietary habits. Participants were 
advised to practice Yoga i.e. Pranayama (breathing 
exercises) and some Asana (postures) like Mandukasana, 
Paschimottasana, Suryanamaskar. The baseline data, 
both subjective and objective was be compared with the 
end line data after 4 weeks of treatment. 
RESULTS AND DISCUSSION 
Results 
 The baseline characteristics of the 64 patients 
taken in the study are given in table 1. Five patients lost 
follow up and they could not be contacted for evaluation. 
Twenty one of the 30 patients receiving Karela attained 
FBG (fasting blood glucose)<130 mg/dl and 12 out of 23 
patients whose PPBG (postprandial blood glucose) 
reports were available, attained a PPBG <180 mg/dl. Two 
patients in this group lost follow up. Nineteen of the 29 
patients receiving attained a FBG of <130 and 14 out of 
25 patients whose PPBG reports were available, attained 
a PPBG value of <180 mg/dl. Three patients in this group 
lost follow up. 
Table 1: Baseline characteristics of patients in Karela and Vijayasar groups 
Characteristics Karela (n=32) Vijayasar (n=32) 
Age# 52.50±10.48 50.00±9.29 
Sex Male 20 16 
Female 12 16 
Duration of diabetes (months)# 12±11.94 24±40.08 
Smoking Current smoker - 6 
Past smoker 8 8 
Never smoked 24 18 
Treatment status On medications 16 18 
Not on medications 16 14 
Activity Sedentary 21 24 
Moderate 11 8 
Heavy - - 
Fasting blood glucose* 187.00±41.85 175.16±43.80 
Post prandial blood glucose* 258.93±86.01 262.59±70.87 
BMI* 26.06±4.89 26.01±30 
Systolic blood pressure* 135.50±18.46 136.44±18.38 
Diastolic blood pressure* 86.50±11.02 87.19±9.91 
Prabhootmutrata (Excessive micturition) 15 13 
Avilmutrata (Increased turbidity of urine) 3 3 
#median±SD, *mean±SD 
 There was no significant difference in the BMI of the Karela treated (p=0.81) or Vijayasar treated (p=0.43) 
patients. There was statistically significant reduction in Fasting blood glucose and post prandial blood glucose in both 
Karela and Vijayasar group. Paired t-test was performed and p value was <0.001.The mean reduction in FBG and PPBG 
in Karela group was 60.83 and 79.74 mg/dl while that in the Vijayasar group was 51.34 and 97.72 mg/dl respectively. 
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There was no statistically significant difference in the blood glucose reductions in both Karela and Vijayasar group 
(p=0.273 for FBG and p=0.791 for PPBG).  
Paired Samples Test 
Drug given Mean SD SEM 
CI of the Difference 
t df p Lower Upper 
Karela powder  FBG_BT- 
FBG_AT 
60.833 37.322 6.814 46.897 74.769 8.928 29 .000 
 PPBG_BT- 
PPBG_AT 
79.739 68.517 14.287 50.110 109.368 5.581 22 .000 
Vijayasar powder  FBG_BT- 
FBG_AT 
51.345 36.714 6.818 37.379 65.310 7.531 28 .000 
 PPBG_BT- 
PPBG_AT 
97.720 55.951 11.190 74.624 120.816 8.733 24 .000 
FBG_AT=Fasting blood glucose before treatment 
PPBG_AT=Post-prandial blood glucose after treatment 
 Pre post MacNemar test was done for analysis of 
categorical variables like Prabhootamutrata and 
Avilmutrata and there statistically significant reduction 
in both these variables after treatment (p<0.001). A 62 
year old female taking Karela powder complained of one 
episode of sweating, shortness of breath, feeling of 
apprehension at night that was relieved after sweet 
intake. She was already on sulfonylurea. Another 62 year 
old female taking Karela complained of generalized 
weakness that disappeared after discontinuing the 
medicine. A 53 year male taking Vijayasar complained of 
new onset of stiffness of extremities in the morning that 
was relieved as day progressed. Patient could not be 
contacted for further evaluation of the complaint, and if it 
persisted after discontinuation of medicine. There was 
one case of treatment failure i.e. FBG>250mg/dl despite 
medication, in Karela group. 
DISCUSSION 
 There was statistically and clinically significant 
reduction in fasting and post-prandial blood glucose in 
both Karela and Vijayasar treated group. The reduction 
in blood glucose was comparable in both groups. Karela 
is supposed to have insulin secreting property so care 
should be taken while prescribing this drug to a patient 
with prolonged diabetes, elderly who are at risk of 
hypoglycemia. 
 Reduction in BMI was expected in Karela treated 
patients based on previous animal experiment which 
revealed significant reduction in body weight of Karela 
treated mice. Contradicting this expectation, there was 
no significant reduction in BMI of those treated with 
Karela or Vijayasar. The duration of one month may not 
be enough to show this effect or the dose of Karela may 
not be enough for weight reduction. Another explanation 
may be that when blood glucose is brought down by the 
medication, the catabolic state of hyperglycaemia is 
corrected and thus regaining the lost body weight of the 
patient cancelling the weight losing property of Karela. 
Vijayasar was reported not to exert any effect on BMI of 
the patients with diabetes and it was corroborated by 
this study. The mean reductions in FBG and PPBG after 
taking Karela churna for one month are 60.83 mg/dl and 
79.74 mg/dl respectively. There was a reduction of 51.34 
mg/dl and 97.72 mg/dl in FBG and PPBG after one 
month of treatment with Vijayasar churna. These 
reductions in both FBG and PPBG in Karela and Vijayasar 
group are not significantly different (p=0.33 and p=0.32 
respectively). Karela possesses the Tikta-katu rasa, 
Laghu-rukshya guna and Katu vipaka while Vijayasar has 
Kasaya-tikta rasa Laghu-rukshya guna and Katu vipaka, 
which helps to normalize the function of Jatharagni and 
checks the formation of Bahuabaddha dhatus by Soshan 
(absorption) of the Bahudravakaphadosha. 
 Diabetes is a chronic ailment and the 
complications brought about by this disease are the core 
concern of the treating physician. This study looked into 
the antidiabetic property of Karela and Vijayasar for a 
period of one month only, which is the major limitation 
besides the small sample size, because diabetes is a 
chronic disease and needs to be managed with lifelong 
medications. A bigger study of at least 5-10 years 
duration could have answered the role of these two 
drugs in reducing the incidence of the micro vascular and 
macro vascular complications of diabetes mellitus.  
CONCLUSION 
 This study was the first study of its kind in Nepal 
which tested the effectiveness of Karela and Vijayasar in 
Madhumeha and compared the two drugs. The clinical 
data of this study supports the view that both these 
drugs are equally potent in controlling blood glucose in 
patients with Madhumeha. There was further evidence 
that Karela churna is as effective as Vijayasar in 
ameliorating the clinical symptoms of Madhumeha like 
Prabhutamutrata, Avilmutrata, etc. Karela churna 
reduced FBG and PPBG by a mean of 60.83 mg/dl and 
79.74 mg/dl respectively while Vijayasar churna reduced 
FBG and PPBG by a mean of 51.34 mg/dl and 97.72 
mg/dl. Although there was a single episode of 
hypoglycemia like symptoms in this study it is advisable 
that precaution be taken to avoid the risks of 
hypoglycemia while prescribing Karela churna in elderly, 
debilitated or patients with long standing diabetes 
mellitus. Both the Karela and Vijayasar churna are 
effective in reducing all symptoms of Madhumeha except 
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Karpadadaha in which there was no significant 
improvement noted in this clinical trial. Both of the trial 
drugs showed significant reduction in systolic and 
diastolic blood pressure and significant proportion of 
hypertensive patients reverted to normal blood pressure 
after one month of treatment. 
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